Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: A meta-analysis

Metabolism: Clinical and Experimental

Volumn 68, Issue , 2017, Pages 119-132

  Katsagoni, Christina N ^a   Georgoulis, Michael ^a   Papatheodoridis, George V ^b   Panagiotakos, Demosthenes B ^a   Kontogianni, Meropi D ^a  

^a HAROKOPIO UNIVERSITY   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Diet; Lifestyle; NAFLD; Physical activity; Weight loss

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARBOHYDRATE; FAT; GLUCOSE; LIVER ENZYME;

AEROBIC EXERCISE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTHROPOMETRIC PARAMETERS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BIBLIOGRAPHIC DATABASE; CARBOHYDRATE DIET; CLINICAL EVALUATION; CLINICAL FEATURE; COCHRANE LIBRARY; DATA ANALYSIS SOFTWARE; DATA SYNTHESIS; DIAGNOSTIC IMAGING; DIET THERAPY; EFFECT SIZE; EXERCISE; EXERCISE INTENSITY; FATTY LIVER; GLUCOSE METABOLISM; HUMAN; LIFESTYLE MODIFICATION; LIVER; LIVER BIOPSY; LIVER FUNCTION; LIVER HISTOLOGY; LOW FAT DIET; MEDICAL SUBJECT HEADINGS; MEDLINE; META ANALYSIS; METABOLIC PARAMETERS; NONALCOHOLIC FATTY LIVER; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLISHING; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESISTANCE TRAINING; SCOPUS; SYSTEMATIC REVIEW; THERAPY EFFECT; LIFESTYLE; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; TREATMENT OUTCOME;

EXERCISE; GLUCOSE; HUMANS; LIFE STYLE; NON-ALCOHOLIC FATTY LIVER DISEASE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 85007277385     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2016.12.006     Document Type: Article

References (63)

1. [1] Neuschwander-Tetri, B.A., Caldwell, S.H., Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology 37 (2003), 1202–1219.
2. [2] Hourigan, S.K., Abrams, S., Yates, K., Pfeifer, K., Torbenson, M., Murray, K., et al. Relation between vitamin D status and nonalcoholic fatty liver disease in children. J Pediatr Gastroenterol Nutr 60 (2015), 396–404.
3. [3] Ratziu, V., Bellentani, S., Cortez-Pinto, H., Day, C., Marchesini, G.A., Position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol 53 (2010), 372–384.
4. [4] Wong, R.J., Aguilar, M., Cheung, R., Perumpail, R.B., Harrison, S.A., Younossi, Z.M., et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology 148 (2015), 547–555.
5. [5] Fazel, Y., Koenig, A.B., Sayiner, M., Goodman, Z.D., Younossi, Z.M., Epidemiology and natural history of non-alcoholic fatty liver disease. Metab Clin Exp 65 (2016), 1017–1025.
6. [6] Miele, L., Targher, G., Understanding the association between developing a fatty liver and subsequent cardio-metabolic complications. Expert Rev Gastroenterol Hepatol 9 (2015), 1243–1245.
7. [7] Kasturiratne, A., Weerasinghe, S., Dassanayake, A.S., Rajindrajith, S., de Silva, A.P., Kato, N., et al. Influence of non-alcoholic fatty liver disease on the development of diabetes mellitus. J Gastroenterol Hepatol 28 (2013), 142–147.
8. [8] Musso, G., Gambino, R., Tabibian, J.H., Ekstedt, M., Kechagias, S., Hamaguchi, M., et al. Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis. PLoS Med, 11, 2014, e1001680.
9. [9] Levene, A.P., Goldin, R.D., The epidemiology, pathogenesis and histopathology of fatty liver disease. Histopathology 61 (2012), 141–152.
10. [10] Teede, H., Deeks, A., Moran, L., Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med, 8, 2010, 41.
11. [11] Preiss, D., Sattar, N., Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations. Clin Sci (Lond) 115 (2008), 141–150.
12. [12] Mahady, S.E., George, J., Exercise and diet in the management of nonalcoholic fatty liver disease. Metabolism 65 (2016), 1172–1182.
13. [13] Musso, G., Cassader, M., Rosina, F., Gambino, R., Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials. Diabetologia 55 (2012), 885–904.
14. [14] Keating, S.E., Hackett, D.A., George, J., Johnson, N.A., Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol 57 (2012), 157–166.
15. [15] Orci, L.A., Gariani, K., Oldani, G., Delaune, V., Morel, P., Toso, C., Exercise-based interventions for nonalcoholic fatty liver disease: a meta-analysis and meta-regression. Clin Gastroenterol Hepatol, 2016.
16. [16] Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Group P, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62 (2009), 1006–1012.
17. [17] Chalasani, N., Younossi, Z., Lavine, J.E., Diehl, A.M., Brunt, E.M., Cusi, K., et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55 (2012), 2005–2023.
18. [18] Sullivan, S., Kirk, E.P., Mittendorfer, B., Patterson, B.W., Klein, S., Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease. Hepatology 55 (2012), 1738–1745.
19. [19] Hallsworth, K., Fattakhova, G., Hollingsworth, K.G., Thoma, C., Moore, S., Taylor, R., et al. Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss. Gut 60 (2011), 1278–1283.
20. [20] Hallsworth, K., Thoma, C., Hollingsworth, K.G., Cassidy, S., Anstee, Q.M., Day, C.P., et al. Modified high-intensity interval training reduces liver fat and improves cardiac function in non-alcoholic fatty liver disease: a randomized controlled trial. Clin Sci (Lond) 129 (2015), 1097–1105.
21. [21] Bacchi, E., Negri, C., Targher, G., Faccioli, N., Lanza, M., Zoppini, G., et al. Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 randomized trial). Hepatology 58 (2013), 1287–1295.
22. [22] Sun, W.H., Song, M.Q., Jiang, C.Q., Xin, Y.N., Ma, J.L., Liu, Y.X., et al. Lifestyle intervention in non-alcoholic fatty liver disease in Chengyang District, Qingdao, China. World J Hepatol 4 (2012), 224–230.
23. [23] St George, A., Bauman, A., Johnston, A., Farrell, G., Chey, T., George, J., Independent effects of physical activity in patients with nonalcoholic fatty liver disease. Hepatology 50 (2009), 68–76.
24. [24] Houghton, D., Thoma, C., Hallsworth, K., Cassidy, S., Hardy, T., Burt, A.D., et al. Exercise reduces liver lipids and visceral adiposity in patients with non-alcoholic steatohepatitis in a randomized controlled trial. Clin Gastroenterol Hepatol, 2016.
25. [25] Angulo, P., Hui, J.M., Marchesini, G., Bugianesi, E., George, J., Farrell, G.C., et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 45 (2007), 846–854.
26. [26] Faraone, S.V., Interpreting estimates of treatment effects: implications for managed care. P T 33 (2008), 700–711.
27. [27] Cohen, J., Statistical power analysis for the behavioral sciences. 1988, L. Erlbaum Associates, Hillsdale, NJ.
28. [28] Egger, M., Zellweger-Zahner, T., Schneider, M., Junker, C., Lengeler, C., Antes, G., Language bias in randomised controlled trials published in English and German. Lancet 350 (1997), 326–329.
29. [29] Yamamoto, M., Iwasa, M., Iwata, K., Kaito, M., Sugimoto, R., Urawa, N., et al. Restriction of dietary calories, fat and iron improves non-alcoholic fatty liver disease. J Gastroenterol Hepatol 22 (2007), 498–503.
30. [30] Zelber-Sagi, S., Buch, A., Yeshua, H., Vaisman, N., Webb, M., Harari, G., et al. Effect of resistance training on non-alcoholic fatty-liver disease a randomized-clinical trial. World J Gastroenterol 20 (2014), 4382–4392.
31. [31] Cuthbertson, D.J., Shojaee-Moradie, F., Sprung, V.S., Jones, H., Pugh, C.J., Richardson, P., et al. Dissociation between exercise-induced reduction in liver fat and changes in hepatic and peripheral glucose homoeostasis in obese patients with non-alcoholic fatty liver disease. Clin Sci (Lond) 130 (2016), 93–104.
32. [32] Pugh, C.J., Spring, V.S., Kemp, G.J., Richardson, P., Shojaee-Moradie, F., Umpleby, A.M., et al. Exercise training reverses endothelial dysfunction in nonalcoholic fatty liver disease. Am J Physiol Heart Circ Physiol 307 (2014), H1298–H1306.
33. [33] Shamsoddini, A., Sobhani, V., Ghamar Chehreh, M.E., Alavian, S.M., Zaree, A., Effect of aerobic and resistance exercise training on liver enzymes and hepatic fat in Iranian men with nonalcoholic fatty liver disease. Hepat Mon, 15, 2015, e31434.
34. [34] Zhang, H.J., He, J., Pan, L.L., Ma, Z.M., Han, C.K., Chen, C.S., et al. Effects of moderate and vigorous exercise on nonalcoholic fatty liver disease: a randomized clinical trial. JAMA Intern Med 176 (2016), 1074–1082.
35. [35] Shojaee-Moradie, F., Cuthbertson, D.J., Barrett, M., Jackson, N.C., Herring, R., Thomas, E.L., et al. Exercise training reduces liver fat and increases rates of VLDL clearance, but not VLDL production in NAFLD. J Clin Endocrinol Metab 101 (2016), 4219–4228.
36. [36] Eckard, C., Cole, R., Lockwood, J., Torres, D.M., Williams, C.D., Shaw, J.C., et al. Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trial. Ther Adv Gastroenterol 6 (2013), 249–259.
37. [37] Borg, G.A., Psychophysical bases of perceived exertion. Med Sci Sports Exerc 14 (1982), 377–381.
38. [38] Pugh, C., Jones, H., Sprung, V., Richardson, P., Shojaee-Moradie, F., Margot Umpleby, A., et al. Improvements in liver fat and endothelial function following supervised exercise training are not sustained one-year after the cessation of supervision in non-alcoholic fatty liver disease: 1948 board #100 June 2, 2:00 PM–3:30 PM. Med Sci Sports Exerc, 48, 2016, 539.
39. [39] Promrat, K., Kleiner, D.E., Niemeier, H.M., Jackvony, E., Kearns, M., Wands, J.R., et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 51 (2010), 121–129.
40. [40] Wong, V.W., Chan, R.S., Wong, G.L., Cheung, B.H., Chu, W.C., Yeung, D.K., et al. Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial. J Hepatol 59 (2013), 536–542.
41. [41] Al-Jiffri, O., Al-Sharif, F.M., Abd El-Kader, S.M., Ashmawy, E.M., Weight reduction improves markers of hepatic function and insulin resistance in type-2 diabetic patients with non-alcoholic fatty liver. Afr Health Sci 13 (2013), 667–672.
42. [42] Rezende, R.E., Duarte, S.M., Stefano, J.T., Roschel, H., Gualano, B., de Sa Pinto, A.L., et al. Randomized clinical trial: benefits of aerobic physical activity for 24 weeks in postmenopausal women with nonalcoholic fatty liver disease. Menopause 23 (2016), 876–883.
43. [43] Ryan, M.C., Itsiopoulos, C., Thodis, T., Ward, G., Trost, N., Hofferberth, S., et al. The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. J Hepatol 59 (2013), 138–143.
44. [44] Arefhosseini, S.R., Ebrahimi-Mameghani, M., Farsad Naeimi, A., Khoshbaten, M., Rashid, J., Lifestyle modification through dietary intervention: health promotion of patients with non-alcoholic fatty liver disease. Health promotion. Perspectives 1 (2011), 147–154.
45. [45] Kani, A.H., Alavian, S.M., Esmaillzadeh, A., Adibi, P., Azadbakht, L., Effects of a novel therapeutic diet on liver enzymes and coagulating factors in patients with non-alcoholic fatty liver disease: a parallel randomized trial. Nutrition 30 (2014), 814–821.
46. [46] Rodriguez-Hernandez, H., Cervantes-Huerta, M., Rodriguez-Moran, M., Guerrero-Romero, F., Decrease of aminotransferase levels in obese women is related to body weight reduction, irrespective of type of diet. Ann Hepatol 10 (2011), 486–492.
47. [47] Wing, R.R., Lang, W., Wadden, T.A., Safford, M., Knowler, W.C., Bertoni, A.G., et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care 34 (2011), 1481–1486.
48. [48] Franz, M.J., Boucher, J.L., Rutten-Ramos, S., VanWormer, J.J., Lifestyle weight-loss intervention outcomes in overweight and obese adults with type 2 diabetes: a systematic review and meta-analysis of randomized clinical trials. J Acad Nutr Diet 115 (2015), 1447–1463.
49. [49] Wilding, J.P., The importance of weight management in type 2 diabetes mellitus. Int J Clin Pract 68 (2014), 682–691.
50. [50] Umpierre, D., Ribeiro, P.A., Schaan, B.D., Ribeiro, J.P., Volume of supervised exercise training impacts glycaemic control in patients with type 2 diabetes: a systematic review with meta-regression analysis. Diabetologia 56 (2013), 242–251.
51. [51] Rankin, A.J., Rankin, A.C., MacIntyre, P., Hillis, W.S., Walk or run? Is high-intensity exercise more effective than moderate-intensity exercise at reducing cardiovascular risk?. Scott Med J 57 (2012), 99–102.
52. [52] Fisher, G., Brown, A.W., Bohan Brown, M.M., Alcorn, A., Noles, C., Winwood, L., et al. High intensity interval- vs moderate intensity-training for improving cardiometabolic health in overweight or obese males: a randomized controlled trial. PLoS One, 10, 2015, e0138853.
53. [53] Sawyer, B.J., Tucker, W.J., Bhammar, D.M., Ryder, J.R., Sweazea, K.L., Gaesser, G.A., Effects of high-intensity interval training and moderate-intensity continuous training on endothelial function and cardiometabolic risk markers in obese adults. J Appl Physiol 121 (2016), 279–288.
54. [54] Marchesini, G., Petta, S., Dalle Grave, R., Diet, weight loss, and liver health in nonalcoholic fatty liver disease: pathophysiology, evidence, and practice. Hepatology 63 (2016), 2032–2043.
55. [55] Borghouts, L.B., Keizer, H.A., Exercise and insulin sensitivity: a review. Int J Sports Med 21 (2000), 1–12.
56. [56] Trefts, E., Williams, A.S., Wasserman, D.H., Chapter nine—exercise and the regulation of hepatic metabolism. Claude, B., (eds.) Progress in molecular biology and translational science: academic press, 2015, 203–225.
57. [57] Passos, E., Ascensao, A., Martins, M.J., Magalhaes, J., Endoplasmic reticulum stress response in non-alcoholic steatohepatitis: the possible role of physical exercise. Metabolism 64 (2015), 780–792.
58. [58] Vilar-Gomez, E., Martinez-Perez, Y., Calzadilla-Bertot, L., Torres-Gonzalez, A., Gra-Oramas, B., Gonzalez-Fabian, L., et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology 149 (2015), 367 e5–378 e5 [quiz e14–5].
59. [59] Vilar, L., Oliveira, C.P., Faintuch, J., Mello, E.S., Nogueira, M.A., Santos, T.E., et al. High-fat diet: a trigger of non-alcoholic steatohepatitis? Preliminary findings in obese subjects. Nutrition 24 (2008), 1097–1102.
60. [60] Moore, J.B., Gunn, P.J., Fielding, B.A., The role of dietary sugars and de novo lipogenesis in non-alcoholic fatty liver disease. Nutrients 6 (2014), 5679–5703.
61. [61] Chung, M., Ma, J., Patel, K., Berger, S., Lau, J., Lichtenstein, A.H., Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis. Am J Clin Nutr 100 (2014), 833–849.
62. [62] Browning, J.D., Baker, J.A., Rogers, T., Davis, J., Satapati, S., Burgess, S.C., Short-term weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction. Am J Clin Nutr 93 (2011), 1048–1052.
63. [63] Chong, M.F., Fielding, B.A., Frayn, K.N., Metabolic interaction of dietary sugars and plasma lipids with a focus on mechanisms and de novo lipogenesis. Proc Nutr Soc 66 (2007), 52–59.